8th Janaushadhi Diwas Celebrated Across the Country with Enthusiastic Participation

1. At a Glance

• Janaushadhi Diwas is observed annually on 7 March to mark the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), the flagship scheme for affordable generic medicines. [S1][S2]
• Implemented by Pharmaceuticals & Medical Devices Bureau of India (PMBI) under the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers. [S1][S3]
• UPSC relevance: GS-II (health, government schemes), GS-III (pharma sector, generics, drug pricing). [S1]

2. Why in the News

• The 8th Janaushadhi Diwas was celebrated on 7 March 2026 across India, marking culmination of week-long Janaushadhi Saptah 2026; Union Minister J P Nadda announced target to expand the network to 25,000 Janaushadhi Kendras by next year. [S1]
• Programs were organised at 25 locations nationwide; awards presented to best-performing Kendra owners by Nadda and MoS Anupriya Patel. [S1]

3. Background & Evolution

• Launched as Jan Aushadhi Campaign in 2008 by the Department of Pharmaceuticals; rebranded and revamped as PMBJP in 2015–16. [S3]
• Operationalised through PMBI (a Society under Department of Pharmaceuticals), formerly BPPI. [S1]
• First Janaushadhi Diwas observed on 7 March 2019; hence 2026 marks the 8th edition. [S2]
• 10,000th Kendra inaugurated by PM at AIIMS Deoghar in 2023, with target raised from 10,000 → 25,000. [S4]

4. Core Static Facts

• Parent body: Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers. [S1]
• Implementing agency: Pharmaceuticals & Medical Devices Bureau of India (PMBI). [S1]
• Annual Diwas date: 7 March. [S2]
• Janaushadhi Saptah 2026: observed 1–7 March 2026; health camps at 250+ locations between 1–5 March 2026. [S2]
• Operational Kendras: >18,000 across India (as of March 2026). [S2]
• Target: 25,000 Kendras (revised timeline announced; expansion goal reiterated by Min. Nadda). [S1][S4]
• Product basket (Feb 2025): 2,047 drugs + 300 surgical/consumable items. [S2]
• Sales milestone: Crossed Rs. 1,000 crore in FY 2023-24. [S5]
• Women empowerment: >8,000 Kendras run by women entrepreneurs. [S2]
• Pricing principle: Generic medicines priced 50–90% lower than branded equivalents (PMBJP design). [S3]

5. Multi-Dimensional Analysis

Economic / Health Financing - Reduces out-of-pocket health expenditure (currently ~47% in India); generics at fraction of branded MRP cut household drug bills. [S3] - Cumulative savings to citizens estimated in thousands of crores; FY24 sales of Rs 1,000+ crore implies ~Rs 5,000+ crore notional savings. [S5]

Social / Equity - Expansion of 8,000+ women-run Kendras advances female entrepreneurship in tier-2/3 towns. [S2] - Coverage of 3,579 blocks across 406 districts in 26 States/UTs under fresh openings. [S6]

Administrative - Eligibility liberalised: individuals, pharmacists, NGOs, hospitals, SHGs can open Kendras with incentives up to Rs 5 lakh. [S3] - Quality assured via WHO-GMP certified suppliers and NABL-accredited lab testing. [S3]

Scientific / Industrial - Aligns with India's "Pharmacy of the World" positioning by promoting domestic generic manufacturers. [S3] - Strengthens National Pharmaceutical Pricing Authority (NPPA) objective of drug affordability. [S3]

6. Recent Developments (12-18 months)

• March 2025: 7th Janaushadhi Diwas with theme "जन औषधि: दाम कम, दवाई उत्तम"; flagged off by Min. Nadda in New Delhi. [S7][S8]
• 2024: 13,822 Kendras operational. [S9]
• 1–5 March 2026: Health camps at 250+ locations under Janaushadhi Saptah. [S2]
• 7 March 2026: 8th Janaushadhi Diwas; 25,000-Kendra expansion target reiterated. [S1]

7. Prelims Hooks

• Janaushadhi Diwas: observed on 7 March every year. [S2]
• First Janaushadhi Diwas observed in 2019 → 2026 = 8th edition. [S1]
• Scheme: Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), launched in current form in 2015–16; campaign origin 2008. [S3]
• Implementing agency: PMBI (Pharmaceuticals & Medical Devices Bureau of India) — NOT NPPA, NOT CDSCO. [S1]
• Parent ministry: Ministry of Chemicals & Fertilizers (Dept of Pharmaceuticals) — NOT Ministry of Health. [S1]
• Operational Kendras (Mar 2026): >18,000. [S2]
• Expansion target: 25,000 Kendras. [S1][S4]
• Product basket: 2,047 medicines + 300 surgicals/consumables. [S2]
• Sales FY 2023-24: crossed Rs 1,000 crore. [S5]
• 10,000th Kendra opened at AIIMS Deoghar (Jharkhand) by PM Modi. [S4]
• Generics priced 50–90% cheaper than branded. [S3]
• >8,000 Kendras run by women. [S2]
• Saptah 2025 theme: "दाम कम, दवाई उत्तम". [S7]

8. Mains Relevance

• GS-II: Government policies/interventions for development in health sector; issues relating to health.
• GS-III: Indian pharmaceutical industry; inclusive growth.

Possible stems: 1. "PMBJP has redefined affordability in India's healthcare landscape, but its impact remains uneven." Critically examine. 2. Discuss the role of generic medicines in reducing out-of-pocket health expenditure in India, with reference to PMBJP. 3. Evaluate the institutional architecture (PMBI, NPPA, CDSCO) supporting affordable medicines in India.

9. Related Topics to Study Next

• National Pharmaceutical Pricing Authority (NPPA) — price ceiling regulator, complements PMBJP.
• Drug Price Control Order (DPCO) 2013 — statutory basis of essential drug pricing.
• National List of Essential Medicines (NLEM) 2022 — defines scheduled drugs.
• Ayushman Bharat (PM-JAY) — demand-side health financing pillar.
• Production-Linked Incentive (PLI) for Pharma & APIs — supply-side support.
• CDSCO / Drugs & Cosmetics Act 1940 — regulatory framework for quality.
• Out-of-Pocket Expenditure & National Health Accounts — outcome metric.
• WHO-GMP certification — quality benchmark for Janaushadhi suppliers.

10. Common Errors / Trap Areas

• Wrong ministry: PMBJP is under Chemicals & Fertilizers, NOT Ministry of Health & Family Welfare.
• Confusing PMBI (implementer) with NPPA (price regulator) or CDSCO (drug regulator).
• Diwas date: 7 March (not 1 March, which is start of Saptah).
• Launch year: campaign began 2008; relaunched as PMBJP in 2015–16 — not 2019 (that's the first Diwas).
• Misremembering target as 10,000 (achieved 2023) instead of revised 25,000.

11. Sources

• [S1] 8th Janaushadhi Diwas Celebrated Across the Country — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2236418 — (tier 1)
• [S2] PMBJP overview (March 2026) — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2236292 — (tier 1)
• [S3] PMBJP: A Journey Towards Affordable Healthcare — https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=2067441 — (tier 1)
• [S4] PM inaugurates 10,000th Jan Aushadhi Kendra at AIIMS Deoghar — https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=1981190 — (tier 1)
• [S5] PMBJP achieved Rs 1000 Cr sales target FY 2023-24 — https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=1988675 — (tier 1)
• [S6] Online applications for Kendras in 3579 blocks — https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=1819197 — (tier 1)
• [S7] Jan Aushadhi Diwas 2025 theme — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2109203 — (tier 1)
• [S8] Nadda inaugurates Jan Aushadhi Diwas 2025 celebrations — https://www.pib.gov.in/PressReleseDetailm.aspx?PRID=2107206 — (tier 1)
• [S9] 13,822 Jan Aushadhi Kendras established — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2061631 — (tier 1)